Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
110
Views
16
CrossRef citations to date
0
Altmetric
Review

Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation

Wolfgang A. Bethge Medical Center, University of Tuebingen, Department of Hematology and Oncology, Tuebingen, Germany
,
D. Scott Wilbur Department of Radiation Oncology, University of Washington, Seattle, WA, USA
&
Brenda M. Sandmaier Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USACorrespondence[email protected]
Pages 1205-1214 | Accepted 16 Nov 2005, Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chitra Hosing. (2010) Hematopoietic stem cell transplantation for the management of follicular lymphoma. Stem Cells and Cloning: Advances and Applications 3, pages 69-80.
Read now

Articles from other publishers (15)

Jingyi Ding, Yanxi Liu & Yu Lai. (2021) Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure. Frontiers in Immunology 12.
Crossref
Scott S. Graves & Rainer Storb. (2020) Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model. Veterinary and Comparative Oncology 18:4, pages 471-483.
Crossref
Muath Helal, Kevin J. H. Allen, Hilary Burgess, Rubin Jiao, Mackenzie E. Malo, Matthew Hutcheson, Ekaterina Dadachova & Elisabeth Snead. (2020) Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections. Molecules 25:16, pages 3604.
Crossref
Martina Sollini, Katia Marzo, Arturo Chiti & Margarita Kirienko. (2020) The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How?. Rendiconti Lincei. Scienze Fisiche e Naturali 31:2, pages 231-247.
Crossref
Sarah A. Buckley & John M. Pagel. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 258 270 .
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 247 290 .
Katie Anderson & Jaime Modiano. (2015) Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure. Veterinary Sciences 2:4, pages 363-387.
Crossref
John M. Pagel & Ajay K. Gopal. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 258 275 .
James G. Douglas & Debra L. Friedman. 2014. ALERT • Adverse Late Effects of Cancer Treatment. ALERT • Adverse Late Effects of Cancer Treatment 657 684 .
Chitra Hosing & Richard E. Champlin. 2013. Lymphoma. Lymphoma 371 402 .
D. Scott Wilbur, Ming-Kuan Chyan, Hirohisa Nakamae, Yun Chen, Donald K. Hamlin, Erlinda B. Santos, Brian T. Kornblit & Brenda M. Sandmaier. (2012) Reagents for Astatination of Biomolecules. 6. An Intact Antibody Conjugated with a Maleimido- closo -Decaborate(2-) Reagent via Sulfhydryl Groups Had Considerably Higher Kidney Concentrations than the Same Antibody Conjugated with an Isothiocyanato- closo -Decaborate(2-) Reagent via Lysine Amines . Bioconjugate Chemistry 23:3, pages 409-420.
Crossref
Eric Schafer & Donald Small. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy 56 76 .
D. Scott Wilbur, Monica S. Thakar, Donald K. Hamlin, Erlinda B. Santos, Ming-Kuan Chyan, Hirohisa Nakamae, John M. Pagel, Oliver W. Press & Brenda M. Sandmaier. (2009) Reagents for Astatination of Biomolecules. 4. Comparison of Maleimido- closo -Decaborate(2-) and meta -[ 211 At]Astatobenzoate Conjugates for Labeling anti-CD45 Antibodies with [ 211 At]Astatine . Bioconjugate Chemistry 20:10, pages 1983-1991.
Crossref
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
A Shimoni, S T Zwas, Y Oksman, I Hardan, N Shem-Tov, A Rand, R Yerushalmi, A Avigdor, I Ben-Bassat & A Nagler. (2007) Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma. Bone Marrow Transplantation 41:4, pages 355-361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.